Incyte Corporation: Revision history

20 August 2022

• curprev 03:3203:32, 20 August 2022 95.149.241.133 talk 1,915 bytes +11 No edit summary undo

13 August 2022

• curprev 03:2803:28, 13 August 2022 109.180.50.163 talk 1,904 bytes +15 No edit summary undo

5 August 2022

• curprev 12:0012:00, 5 August 2022 >Paris 1,889 bytes +1,889 Created page with "Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and..."